Search Results for 'patients'

Contract Service Directory Companies

View All Buyers Guide Companies »

• Drug Delivery | Injectables
  

  Self-Medication: Flexibility for Patients and Drug Manufacturers

  Bringing together self-medication with auto-injectors and sustainable secondary packaging.

  Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20
  

  ---

• Breaking News | Clinical Trials
  

  Thermo Fisher Expands Direct-to-Patient Service

  Offering now includes Clinical Site-to-Patient, Pharmacy-to-Patient and Depot-to-Patient services to enable medication delivery directly to patients' homes.

  Contract Pharma Staff 10.27.20
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
  

  Lilly Pauses ACTIV-3 Clinical Trial in Hospitalized COVID-19 Patients

  ACTIV-3 study is evaluating the efficacy of Lilly’s neutralizing antibody in hospitalized COVID-19 patients, the most advanced stage of the disease.

  Contract Pharma Staff 10.16.20
  

  ---

• Breaking News | Collaborations & Alliances | Industry News
  

  Ethypharm and RSSL Fast-Track Medicine for COVID-19 Patients

  Collaborate to accelerate the manufacture and batch release of fentanyl injection

  Contract Pharma Staff 06.04.20
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Lilly, AbCellera Dose First Patients with COVID-19 Antibody

  Phase 1 study of LY-CoV555 is the world's first study of a potential antibody treatment designed to fight COVID-19

  Contract Pharma Staff 06.01.20
  

  ---

• Clinical Trials | Drug Development
  

  How to Design Trials to be More Patient-Centered

  Three lessons learned and how pharma can use validated measures and strategies to engage patients at every stage in the drug development lifecycle.

  Jean Paty, Vice President, Patient Centered Sciences, IQVIA, Matthew Reaney, Senior Principal, Patient Centered Sciences, IQVIA 04.16.20
  

  ---

• Drug Development | Industry News
  

  Leading BioSciences Drug May Help Critical COVID-19 Patients

  Investigational drug, LB1148, being considered to treat respiratory distress and organ dysfunction in critically ill COVID-19 patients

  04.08.20
  

  ---

• Breaking News | Trials & Filings
  

  Altasciences Completes Phase I Study in COVID-19 Patients

  Gimsilumab, a monoclonal antibody, is being evaluated in patients with or at risk of developing acute respiratory distress syndrome

  03.27.20
  

  ---